Literature DB >> 20172025

Action of 6-amino-3-pyridinols as novel antioxidants against free radicals and oxidative stress in solution, plasma, and cultured cells.

Yo Omata1, Yoshiro Saito, Yasukazu Yoshida, Byeong-Seon Jeong, Remigiusz Serwa, Tae-gyu Nam, Ned A Porter, Etsuo Niki.   

Abstract

Free radical-mediated lipid peroxidation has been implicated in the pathogenesis of various diseases. Lipid peroxidation products are cytotoxic and they modify proteins and DNA bases, leading eventually to degenerative disorders. Various synthetic antioxidants have been developed and assessed for their capacity to inhibit lipid peroxidation and oxidative stress induced by free radicals. In this study, the capacity of novel 6-amino-2,4,5-trimethyl-3-pyridinols for scavenging peroxyl radicals, inhibiting plasma lipid peroxidation in vitro, and preventing cytotoxicity induced by glutamate, 6-hydroxydopamine, 1-methyl-4-phenylpyridium (MPP(+) ), and hydroperoxyoctadecadienoic acid was assessed. It was found that they exerted higher reactivity toward peroxyl radicals and more potent activity for inhibiting the above oxidative stress than alpha-tocopherol, the most potent natural antioxidant, except against the cytotoxicity induced by MPP(+). These results suggest that the novel 6-amino-3-pyridinols may be potent antioxidants against oxidative stress. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20172025     DOI: 10.1016/j.freeradbiomed.2010.02.018

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice.

Authors:  Hoyul Lee; Joon Seop Lee; Hyun Jung Cho; Yu-Jeong Lee; Eun Soo Kim; Sung Kook Kim; Tae-Gyu Nam; Byeong-Seon Jeong; Jung-Ae Kim
Journal:  Dig Dis Sci       Date:  2020-05-02       Impact factor: 3.199

2.  Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection.

Authors:  Maike J Ohlow; Selina Sohre; Matthias Granold; Mathias Schreckenberger; Bernd Moosmann
Journal:  Pharm Res       Date:  2016-11-28       Impact factor: 4.200

3.  An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Zeljka Korade; Dale A Rosado; Wei Liu; Connor R Lamberson; Ned A Porter
Journal:  J Lipid Res       Date:  2011-03-14       Impact factor: 5.922

4.  BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Youra Kang; Maheshwor Timilshina; Tae-Gyu Nam; Byeong-Seon Jeong; Jae-Hoon Chang
Journal:  Biol Res       Date:  2017-02-28       Impact factor: 5.612

5.  Synthesis of Pyridoxine-Derived Dimethylpyridinols Fused with Aminooxazole, Aminoimidazole, and Aminopyrrole.

Authors:  Bhuwan Prasad Awasthi; Hyunji Lee; Byeong-Seon Jeong
Journal:  Molecules       Date:  2022-03-23       Impact factor: 4.411

6.  BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.

Authors:  Suhrid Banskota; Jaya Gautam; Sushil C Regmi; Pallavi Gurung; Myo-Hyeon Park; Seung Joo Kim; Tae-Gyu Nam; Byeong-Seon Jeong; Jung-Ae Kim
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.